Post-earnings recap
Reported
Tue, Aug 9, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
13%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bausch Health Companies Inc. reported a significant miss on EPS, which contributed to a sharp decline in its stock price by 11.3%. The lack of revenue data and guidance updates adds uncertainty about the company's future performance. Investors may be concerned about the company's financial health moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.40 | N/A | -144.94% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.